TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
39.49
+1.50 (3.95%)
Apr 23, 2025, 4:00 PM EDT - Market closed
TG Therapeutics Market Cap
TG Therapeutics has a market cap or net worth of $5.74 billion as of April 23, 2025. Its market cap has increased by 155.78% in one year.
Market Cap
5.74B
Enterprise Value
5.68B
1-Year Change
155.78%
Ranking
Category
Stock Price
$39.49
Market Cap Chart
Since May 3, 2010, TG Therapeutics's market cap has increased from $9.10M to $5.74B, an increase of 62,922.13%. That is a compound annual growth rate of 53.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2025 | 5.97B | 27.35% |
| Dec 31, 2024 | 4.69B | 81.18% |
| Dec 29, 2023 | 2.59B | 50.41% |
| Dec 30, 2022 | 1.72B | -36.69% |
| Dec 31, 2021 | 2.72B | -60.29% |
| Dec 31, 2020 | 6.84B | 518.96% |
| Dec 31, 2019 | 1.11B | 225.13% |
| Dec 31, 2018 | 339.90M | -41.33% |
| Dec 29, 2017 | 579.30M | 127.62% |
| Dec 30, 2016 | 254.50M | -59.38% |
| Dec 31, 2015 | 626.60M | -10.02% |
| Dec 31, 2014 | 696.40M | 433.23% |
| Dec 31, 2013 | 130.60M | 43.20% |
| Dec 31, 2012 | 91.20M | 91,100.00% |
| Dec 30, 2011 | 100.00K | -97.92% |
| Dec 31, 2010 | 4.80M | -47.25% |
View and export this data all the way back to 2010.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 739.72B |
| UnitedHealth Group | 388.74B |
| Johnson & Johnson | 372.35B |
| AbbVie | 311.76B |
| Novo Nordisk | 276.62B |
| Abbott Laboratories | 224.33B |
| Novartis AG | 211.63B |
| AstraZeneca | 210.34B |